| Income statement (x € million, continuing operations) |
2011 |
2010 |
| |
|
|
| Net sales |
9,048 |
8,176 |
| |
|
|
| Operating profit before depreciation and amortization (EBITDA) |
1,296 |
1,161 |
| |
|
|
| Operating profit before exceptional items |
866 |
752 |
| Net finance costs |
(82) |
(93) |
| Share of the profit of associates |
3 |
5 |
| Income tax expense |
(147) |
(162) |
| Profit attributable to non-controlling interests |
(46) |
(18) |
| |
|
|
| Net profit before exceptional items |
594 |
484 |
| Net profit from discontinued operations, excluding exceptional items |
21 |
63 |
| Net result from exceptional items |
199 |
(40) |
| |
|
|
| Total net profit attributable to equity holders of Koninklijke DSM N.V. |
814 |
507 |
| |
|
|
| ROCE, continuing operations (in %) |
14.0 |
14.6 |
| EBITDA / net sales, continuing operations (in %) |
14.3 |
14.2 |
